While the mechanisms underlying the immunomodulatory function of K17 are not fully understood and have not been explored in pancreatic cancer, previously published data suggests that K17 expression has been associated with the production of pro-inflammatory cytokines and chemokines that regulate the recruitment of immune cells to sites of inflammation and modulate immune responses. Here, KRT17 is linked to familial pancreatic carcinoma.